Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $816,486 - $1.01 Million
-3,479 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$224.85 - $279.04 $255,654 - $317,268
1,137 Added 48.55%
3,479 $961,000
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $304,035 - $374,158
1,372 Added 141.44%
2,342 $541,000
Q2 2021

Aug 10, 2021

SELL
$180.55 - $233.54 $189,577 - $245,217
-1,050 Reduced 51.98%
970 $223,000
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $104,507 - $135,289
636 Added 45.95%
2,020 $377,000
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $143,375 - $189,720
-1,099 Reduced 44.26%
1,384 $234,000
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $71,647 - $82,873
490 Added 24.59%
2,483 $368,000
Q2 2020

Aug 11, 2020

SELL
$136.42 - $164.18 $31,240 - $37,597
-229 Reduced 10.31%
1,993 $327,000
Q1 2020

May 08, 2020

BUY
$119.05 - $147.35 $264,529 - $327,411
2,222 New
2,222 $308,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Agf Investments Inc. Portfolio

Follow Agf Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments Inc. with notifications on news.